Chemotherapy, Radiotherapy and Bevacizumab in Patients With Unresectable Stage III Non-Small-Cell Lung Cancer

NCT00402883 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped Terminated due to bevacizumab and chemoradiotherapy toxicity

Conditions

Lung Cancer

Interventions

DRUG: Bevacizumab
DRUG: Pemetrexed
PROCEDURE: Radiotherapy
OTHER: Folic Acid
OTHER: vitamin B12
DRUG: carboplatin

Sponsor

SCRI Development Innovations, LLC

Collaborators

[object Object]
[object Object]